Affordable Access

Access to the full text

The Effect of Tigecycline on the Binding of Fluoroquinolones to Human Serum Albumin

Authors
  • Jelic, Ratomir M.
  • Stojanovic, Stefan D.
  • Beric, Jelena D.
  • Odovic, Jadranka
Type
Published Article
Journal
Serbian Journal of Experimental and Clinical Research
Publisher
De Gruyter Open
Publication Date
Mar 01, 2018
Volume
19
Issue
1
Pages
17–25
Identifiers
DOI: 10.1515/sjecr-2017-0006
Source
De Gruyter
Keywords
License
Green

Abstract

The co-administration of several drugs in multidrug therapy may alter the binding of each drug to human serum albumin (HSA) and, thus, their pharmacology effect. Therefore, in this study, the interaction mechanism between HSA and two fluoroquinolones (FQs), sparfloxacin (SPF) and levofloxacin (LVF), was investigated using fluorescence and absorption methods in the absence and presence of the competing drugtigecycline (TGC). The the UV-Vis and fluorescence spectroscopy results showed that the fluorescence quenching of HSA was a result of the formation of the HSA-SPF and HSA-LVF complexes. The fluorescence quenching of HSA-TGC revealed that tigecycline can regulate the binding sites, binding mode and binding affinity of fluoroquinolones. The binding constants (KA) and binding sites (n) of the interaction systems were calculated. The results confirmed that the KA values of the HSA-FQ system decreased in the presence of TGC, indicating that TGC can affect the binding ability of FQ for HSA. This interaction may increase the free plasma concentration of unbound FQ and enhance their pharmacology effect.

Report this publication

Statistics

Seen <100 times